KYTX (Kyverna Therapeutics) Non Operating Income : $-0.09 Mil (TTM As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Kyverna Therapeutics Non Operating Income?

Non Operating Income is income or expense that comes from miscellaneous sources. Kyverna Therapeutics's Non Operating Income for the three months ended in Dec. 2024 was $0.00 Mil. Its Non Operating Income for the trailing twelve months (TTM) ended in Dec. 2024 was $-0.09 Mil.

Kyverna Therapeutics Non Operating Income Historical Data

The historical data trend for Kyverna Therapeutics's Non Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kyverna Therapeutics Non Operating Income Chart

Kyverna Therapeutics Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Non Operating Income

-0.01

-0.06

-0.09

Kyverna Therapeutics Quarterly Data
	Dec21	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Non Operating Income	Get a 7-Day Free Trial					-0.03	-0.03	-0.02	-0.05	-

Kyverna Therapeutics Non Operating Income Calculation

Non Operating Income is income or expense that comes from miscellaneous sources.

Non Operating Income for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.09 Mil.

Kyverna Therapeutics Non Operating Income Related Terms

Thank you for viewing the detailed overview of Kyverna Therapeutics's Non Operating Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Kyverna Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kyverna Therapeutics Inc (NAS:KYTX) » Definitions » Non Operating Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

5980 Horton Street, Suite 550, Emeryville, CA, USA, 94608

Website

https://www.kyvernatx.com

Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product, KYV-101, is an autologous CD19 CAR T-cell product candidate made from an underlying chimeric antigen receptor, or CAR. It is also developing KYV-201, an allogeneic therapy containing the same CAR as KYV-101, to develop it in multiple autoimmune diseases.